{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:42Z","timestamp":1740107202085,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81172561"],"award-info":[{"award-number":["No.81172561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["No. 2014CB541700"],"award-info":[{"award-number":["No. 2014CB541700"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Science and Technology of Zhejiang Province","award":["No. 2015C03035"],"award-info":[{"award-number":["No. 2015C03035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00405-020-06557-9","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T13:02:47Z","timestamp":1609678967000},"page":"3921-3931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic risk factors for initially diagnosed T2N0M0 glottic cancer: competing risk analysis and propensity-score matched cohort analysis"],"prefix":"10.1007","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9477-3519","authenticated-orcid":false,"given":"Guan-Jiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei-Bei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"6557_CR1","doi-asserted-by":"crossref","unstructured":"Pfister DG, Spencer S, Adelstein D et al (2020) NCCN clinical practice guidelines in oncology: head and neck cancers (Version 1, 2020). Available at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 12 Feb 2020","DOI":"10.6004\/jnccn.2020.0031"},{"key":"6557_CR2","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/hed.24520","volume":"38","author":"P Bhateja","year":"2016","unstructured":"Bhateja P, Ward MC, Hunter GH et al (2016) Impaired vocal cord mobility in T2N0 glottic carcinoma: suboptimal local control with radiation alone. Head Neck 38:1832\u20131836","journal-title":"Head Neck"},{"key":"6557_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/coa.12790","volume":"42","author":"L Warner","year":"2017","unstructured":"Warner L, Lee K, Homer JJ (2017) Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes. Clin Otolaryngol 42:629\u2013636","journal-title":"Clin Otolaryngol"},{"key":"6557_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MOO.0000000000000438","volume":"26","author":"M Hendriksma","year":"2018","unstructured":"Hendriksma M, Heijnen BJ, Sjogren EV (2018) Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature. Curr Opin Otolaryngol Head Neck Surg 26:84\u201393","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"6557_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hed.24816","volume":"39","author":"J Yesensky","year":"2017","unstructured":"Yesensky J, Agrawal N, Bayan S et al (2017) AHNS series\u2014Do you know your guidelines? Principles of treatment for glottic cancer: a review of the National Comprehensive Cancer Network guidelines. Head Neck 39:1729\u20131732","journal-title":"Head Neck"},{"key":"6557_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hed.21687","volume":"34","author":"K Mantsopoulos","year":"2012","unstructured":"Mantsopoulos K, Psychogios G, Koch M, Zenk J, Waldfahrer F, Iro H (2012) Comparison of different surgical approaches in T2 glottic cancer. Head Neck 34:73\u201377","journal-title":"Head Neck"},{"key":"6557_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26308","author":"FK Al","year":"2020","unstructured":"Al FK, Youssef BY, Mohamed A et al (2020) Outcomes after radiation therapy for T2N0\/stage II glottic squamous cell carcinoma. Head Neck. https:\/\/doi.org\/10.1002\/hed.26308 (Epub ahead of print)","journal-title":"Head Neck"},{"key":"6557_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/02841860500490269","volume":"45","author":"R Murakami","year":"2006","unstructured":"Murakami R, Nishimura R, Baba Y, Yumoto E, Oya N, Yamashita Y (2006) Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system. Acta Oncol 45:162\u2013167","journal-title":"Acta Oncol"},{"key":"6557_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamaoncol.2015.0764","volume":"1","author":"SJ Katz","year":"2015","unstructured":"Katz SJ (2015) Cancer Care Delivery Research and the National Cancer Institute SEER Program: challenges and opportunities. JAMA Oncol 1:677\u2013678","journal-title":"JAMA Oncol"},{"key":"6557_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA 317:1338\u20131348","journal-title":"JAMA"},{"key":"6557_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12350-017-1012-y","volume":"25","author":"CJ Morgan","year":"2018","unstructured":"Morgan CJ (2018) Reducing bias using propensity score matching. J Nucl Cardiol 25:404\u2013406","journal-title":"J Nucl Cardiol"},{"key":"6557_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","volume":"17","author":"AG Renehan","year":"2016","unstructured":"Renehan AG, Malcomson L, Emsley R et al (2016) Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 17:174\u2013183","journal-title":"Lancet Oncol"},{"key":"6557_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0194599819838823","volume":"161","author":"EA Jones","year":"2019","unstructured":"Jones EA, Shuman AG, Egleston BL, Liu JC (2019) common pitfalls of head and neck research using cancer registries. Otolaryngol Head Neck Surg 161:245\u2013250","journal-title":"Otolaryngol Head Neck Surg"},{"key":"6557_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.21558","author":"L Thomas","year":"2020","unstructured":"Thomas L, Li F, Pencina M (2020) Using propensity score methods to create target populations in observational clinical research. JAMA. https:\/\/doi.org\/10.1001\/jama.2019.21558 (Epub ahead of print)","journal-title":"JAMA"},{"key":"6557_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7819","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ (2020) Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.7819 (Epub ahead of print)","journal-title":"JAMA"},{"key":"6557_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/hed.23389","volume":"36","author":"M Canis","year":"2014","unstructured":"Canis M, Martin A, Ihler F et al (2014) Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma\u2014results of 391 patients. Head Neck 36:859\u2013866","journal-title":"Head Neck"},{"key":"6557_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hed.23688","volume":"37","author":"M Canis","year":"2015","unstructured":"Canis M, Ihler F, Martin A, Matthias C, Steiner W (2015) Transoral laser microsurgery for T1a glottic cancer: review of 404 cases. Head Neck 37:889\u2013895","journal-title":"Head Neck"},{"key":"6557_CR18","first-page":"4295960","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang B, Sun G, Zhang G, Lu L, Liang G (2018) Carbon dioxide laser microsurgery versus low-temperature plasma radiofrequency ablation for T1a glottic cancer: a single-blind randomized clinical trial. Biomed Res Int 2018:4295960","journal-title":"Biomed Res Int"},{"key":"6557_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/hed.26052","volume":"42","author":"SY Chung","year":"2020","unstructured":"Chung SY, Lee CG (2020) Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer. Head Neck 42:854\u2013859","journal-title":"Head Neck"},{"key":"6557_CR20","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/MLG.0b013e3181781791","volume":"118","author":"T Nomiya","year":"2008","unstructured":"Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S (2008) Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 118:1417\u20131421","journal-title":"Laryngoscope"},{"key":"6557_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03049-4","author":"D De Seta","year":"2020","unstructured":"De Seta D, Campo F, D\u2019Aguanno V et al (2020) Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up. Lasers Med Sci. https:\/\/doi.org\/10.1007\/s10103-020-03049-4 (Epub ahead of print)","journal-title":"Lasers Med Sci"},{"key":"6557_CR22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1017\/S002221511500184X","volume":"129","author":"P Gorphe","year":"2015","unstructured":"Gorphe P, Blanchard P, Breuskin I, Temam S, Tao Y, Janot F (2015) Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx. J Laryngol Otol 129:903\u2013909","journal-title":"J Laryngol Otol"},{"key":"6557_CR23","doi-asserted-by":"publisher","first-page":"E1319","DOI":"10.3390\/cancers11091319","volume":"11","author":"M Hendriksma","year":"2019","unstructured":"Hendriksma M, Ruler M, Verbist BM et al (2019) Survival and prognostic factors for outcome after radiotherapy for T2 glottic carcinoma. Cancers (Basel) 11:E1319","journal-title":"Cancers (Basel)"},{"key":"6557_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13014-017-0915-8","volume":"12","author":"LM Dixon","year":"2017","unstructured":"Dixon LM, Douglas CM, Shaukat SI et al (2017) Conventional fractionation should not be the standard of care for T2 glottic cancer. Radiat Oncol 12:178","journal-title":"Radiat Oncol"},{"key":"6557_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091\u20132098","journal-title":"N Engl J Med"},{"key":"6557_CR26","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"GT Wolf","year":"1991","unstructured":"Wolf GT, Fisher SG, Hong WK et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685\u20131690","journal-title":"N Engl J Med"},{"key":"6557_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/COC.0b013e3181beaab0","volume":"33","author":"DA Jones","year":"2010","unstructured":"Jones DA, Mendenhall CM, Kirwan J et al (2010) Radiation therapy for management of t1\u2013t2 glottic cancer at a private practice. Am J Clin Oncol 33:587\u2013590","journal-title":"Am J Clin Oncol"},{"key":"6557_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/jjco\/hyq077","volume":"40","author":"M Nakayama","year":"2010","unstructured":"Nakayama M, Hayakawa K, Okamoto M, Niibe Y, Ishiyama H, Kotani S (2010) Phase I\/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer. Jpn J Clin Oncol 40:921\u2013926","journal-title":"Jpn J Clin Oncol"},{"key":"6557_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11604-005-1517-1","volume":"24","author":"Y Itoh","year":"2006","unstructured":"Itoh Y, Fuwa N (2006) Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer. Radiat Med 24:277\u2013281","journal-title":"Radiat Med"},{"key":"6557_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1748-717X-7-122","volume":"7","author":"N Hirasawa","year":"2012","unstructured":"Hirasawa N, Itoh Y, Naganawa S et al (2012) Multi-institutional analysis of early glottic cancer from 2000 to 2005. Radiat Oncol 7:122","journal-title":"Radiat Oncol"},{"key":"6557_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00405-015-3579-8","volume":"273","author":"Y Kitani","year":"2016","unstructured":"Kitani Y, Kubota A, Furukawa M, Sato K (2016) Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy. Eur Arch Otorhinolaryngol 273:1011\u20131017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"6557_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/lary.26259","volume":"127","author":"S Cheraghlou","year":"2017","unstructured":"Cheraghlou S, Kuo P, Judson BL (2017) Treatment delay and facility case volume are associated with survival in early-stage glottic cancer. Laryngoscope 127:616\u2013622","journal-title":"Laryngoscope"},{"key":"6557_CR33","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMp038171","volume":"349","author":"EE Vokes","year":"2003","unstructured":"Vokes EE, Stenson KM (2003) Therapeutic options for laryngeal cancer. N Engl J Med 349:2087\u20132089","journal-title":"N Engl J Med"},{"key":"6557_CR34","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/hed.25674","volume":"41","author":"O Laccourreye","year":"2019","unstructured":"Laccourreye O, Marret G, Rubin F et al (2019) Ten-year outcome of curative \u201cexclusive\u201d chemotherapy in N0M0 squamous cell carcinoma of the larynx and pharynx with complete clinical response. Head Neck 41:2190\u20132196","journal-title":"Head Neck"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-020-06557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-020-06557-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-020-06557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T18:07:43Z","timestamp":1629742063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-020-06557-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["6557"],"URL":"https:\/\/doi.org\/10.1007\/s00405-020-06557-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"5 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval and patient written informed consent were not required, because all analyses in our study were mainly performed based on data from the SEER database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}